THe initial event in glucose-stimulated insulin secretion by pancreatic islet beta cells is the facilitated of glucose across the cell membrane via a glucose transporter (GT) protein. The GT protein family be subdivided, on the basis of functional transport kinetics and tissue-specific expression, into three GT the brain/erythrocyte GT, the islet/liver GT, and the adipocyte/muscle GT. Although the three GT share amino acid homology and a common predicted protein structure, there is little information regarding the structure-function relationship of the GT proteins or regarding which domains of each GT are responsible for the distinctive glucose transport kinetics of each GT species. In the proposed project, putative proteins domains encoded by the islet GT cDNA and adipocyte GT cDNA will be exchanged produce chimeric islet-adipocyte GT cDNAs. The chimeric GT cDNAs will be expressed in Xenopus oocytes and the Km and Vmax for glucose influx and efflux, the Km and Vmax under equilibrium exchange and the binding constants for cytochalasin B determined. These kinetic properties differ markedly between the islet GT and the adipocyte GT. Comparison of the kinetics of glucose transport between the chimeric and the unmodified islet and adipocyte GTs will identify protein domains responsible for the distinctive kinetics of each GT species. Based on this information, precise mapping of the amino acid residue(s) responsible for the distinctive kinetic properties will be achieved by site-directed mutagenesis. In parallel approach to study the structure-function of the islet GT, the islet GT from an insulin-producing islet line with abnormal glucose transport kinetics despite normal levels of the islet GT RNA will be characterized by expression in oocytes, by determination of the nucleotide sequence and by immunoblotting with an islet GT specific antiserum. This will investigate the role of either a mutation in the islet GT cDNA or an islet cellular factor that suppresses the function of the islet GT and will provide insight into the function the normal islet GT protein. The proposed project will utilize recent advances in GT molecular biology to elucidate the domains the islet GT protein responsible for its unique functional characteristics and to identify structure-function relationships of the islet and adipocyte GT proteins. These results will provide new insights into the molecular mechanisms of glucose transport in islet cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK043736-01
Application #
3245194
Study Section
Metabolism Study Section (MET)
Project Start
1991-07-01
Project End
1994-06-30
Budget Start
1991-07-01
Budget End
1992-06-30
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Sridharan, Rupa; Smale, Stephen T (2007) Predominant interaction of both Ikaros and Helios with the NuRD complex in immature thymocytes. J Biol Chem 282:30227-38
Ziegler, B; Schlosser, M; Luhder, F et al. (1996) Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome. Acta Diabetol 33:225-31
Daw, K; Ujihara, N; Atkinson, M et al. (1996) Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J Immunol 156:818-25
Vinik, A I; Leichter, S B; Pittenger, G L et al. (1995) Phospholipid and glutamic acid decarboxylase autoantibodies in diabetic neuropathy. Diabetes Care 18:1225-32
Daw, K; Powers, A C (1995) Two distinct glutamic acid decarboxylase auto-antibody specificities in IDDM target different epitopes. Diabetes 44:216-20
Buchs, A; Wu, L; Morita, H et al. (1995) Two regions of GLUT 2 glucose transporter protein are responsible for its distinctive affinity for glucose. Endocrinology 136:4224-30
Due, A D; Qu, Z C; Thomas, J M et al. (1995) Role of the C-terminal tail of the GLUT1 glucose transporter in its expression and function in Xenopus laevis oocytes. Biochemistry 34:5462-71
Due, A D; Cook, J A; Fletcher, S J et al. (1995) A ""cysteineless"" GLUT1 glucose transporter has normal function when expressed in Xenopus oocytes. Biochem Biophys Res Commun 208:590-6
Ujihara, N; Daw, K; Gianani, R et al. (1994) Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes. Diabetes 43:968-75
Morita, H; Yano, Y; Niswender, K D et al. (1994) Coexpression of glucose transporters and glucokinase in Xenopus oocytes indicates that both glucose transport and phosphorylation determine glucose utilization. J Clin Invest 94:1373-82

Showing the most recent 10 out of 12 publications